Heidelberg Epignostix
We combine world-leading scientific and medical expertise with cutting-edge technical innovation, to improve diagnostic accuracy and enhance clinical care for cancer patients.
Who We Are
We are passionate about improving diagnostic accuracy.
Accurate and precise diagnosis is crucial for optimal management of patients with cancer. Our vision is to help create a world in which all cancer patients are treated appropriately and as individuals, by providing innovative solutions for precision molecular diagnostics.
Our team reflects the interdisciplinary collaboration required to solve this challenge in oncology, from statistics and data science to genetics, pathology and healthcare.
What We Do
We combine world-leading scientific and medical expertise with cutting-edge technical innovation.
The company has developed its expertise since its establishment in 2022, building on decades of combined experience of its founders. We conduct research and development, certification and marketing of software solutions for molecular tumour classification based on DNA methylation profiling and machine learning. Find out about our breakthrough technology here.
As we continue to refine our classifiers through rigorous research and development, we remain committed to transforming cancer care through innovation and scientific excellence. Stay tuned for updates on our latest breakthroughs and the launch of our classifiers, aimed at making a significant impact in the fight against cancer.
Join us on this transformative journey to unlock the potential of DNA methylation analysis for cancer classification. Together, we can pave the way for a future where precise and personalised treatments become a reality for patients worldwide!